Onyx Expands Capabilities

Onyx Scientific has entered an alliance with UK-based Reach Separations, a purification specialist, allowing Onyx to deliver more specialist purification and separation services for early stage development.
 
Onyx Scientific will now offer custom separation for companies in drug discovery and intermediate environments, including chiral, reverse phase and normal phase chromatography using Supercritical Fluid Chromatography (SFC) and High Performance Liquid Chromatography (HPLC).
 
Onyx Scientific supports pharma and biopharma companies from medicinal chemistry and preclinical through Phase I-III, scaling-up to large-scale commercial API production.
 
Denise Bowser, commercial director at Onyx Scientific, said, “We were very impressed with the major equipment investment at Reach Separations and the team’s exceptional knowledge in understanding our clients’ challenges in small scale purification. We expect this strategic partnership will play an important role in giving our clients quicker access to these types of services but with the added benefit of knowing it will be managed by us as part of the overall project.” 
 
Technical director at Reach Separations, Phil Abbott, said, “We are delighted to be working alongside Onyx Scientific given the company’s fine reputation in contract medicinal chemistry, scaleup and manufacturing for the world’s drug development industry. Our role will be to bring our expertise to the table and work as part of the Onyx team to ensure clients’ requirements are always met and timelines never exceeded.”